
Review article
Select search scope: search across all journals or within the current journal







OBJECTIVE: To evaluate tone perception performance in Cantonese-speaking prelingually hearing-impaired children with cochlear implants.
STUDY DESIGN AND SETTING: The ability to discriminate and identify Cantonese tones was evaluated on 17 native Cantonese-speaking prelingually hearing-impaired children. Performance was correlated to factors like age of implantation and general communication ability.
RESULTS: Subjects' performance in discrimination and identification tasks was slightly above chance level. Although variations in the contour fundamental frequency of the tones provided some cues for tone discrimination, these distinctions proved insufficient for subjects to perform well. Tone 6 (low level tone) was the most difficult to identify. Subjects' performance did not correlate with gender, age of implantation, duration of implant use, frequency of auditory training session, or general communication ability.
CONCLUSION: Although some children were able to discriminate and/or identify Cantonese tones, their performance was poor. Further studies are needed to understand how tone perception relate to daily speech understanding.
SIGNIFICANCE: Cochlear implant speech coding strategies may need modification to optimize tone perception. (Otolaryngol Head Neck Surg 2004; 130:751-8.)
This paper reports on an evidence-based review of laryngeal electromyography (EMG) as a technique for use in the diagnosis, prognosis, and treatment of laryngeal movement disorders including the laryngeal dystonias, vocal fold paralysis, and other neurolaryngological disorders. The authors performed a systematic review of the medical literature from 1944 through 2001 on the clinical application of EMG to laryngeal disorders. The review yielded 584 articles of which 33 met the predefined inclusion criteria. The evidence demonstrated that in a double-blind treatment trial of botulinum toxin versus saline, laryngeal EMG used to guide injections into the thyroarytenoid muscle in persons with adductor spasmodic dysphonia was beneficial. A cross-over comparison between laryngeal EMG-guided injection and endoscopic injection of botulinum toxin into the posterior cricoarytenoid muscle in abductor spasmodic dysphonia found no significant difference between the 2 techniques and no significant treatment benefit. Based on the evidence, laryngeal EMG is possibly useful for the injection of botulinum toxin into the thyroarytenoid muscle in the treatment of adductor spasmodic dysphonia. There were no evidence-based data sufficient to support or refute the value of laryngeal EMG for the other uses investigated, although there is extensive anecdotal literature suggesting that it is useful for each of them. There is an urgent need for evidence-based research addressing other applications in the use of laryngeal EMG for other applications. (Otolaryngol Head Neck Surg 2004;130: 770-9.)





